4.7 Article

Duchenne Muscular Dystrophy from Brain to Muscle: The Role of Brain Dystrophin Isoforms in Motor Functions

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Startle responses in Duchenne muscular dystrophy: a novel biomarker of brain dystrophin deficiency

Kate Maresh et al.

Summary: Duchenne muscular dystrophy (DMD) patients, in addition to muscle loss, also experience intellectual disability and neurobehavioral co-morbidities. This study shows that boys with DMD exhibit increased startle responses to threat, similar to a DMD mouse model, and these responses normalize with dystrophin restoration.
Article Neurosciences

Gene therapy for selected neuromuscular and trinucleotide repeat disorders-An insight to subsume South Asia for multicenter clinical trials

Nalaka Wijekoon et al.

Summary: This article discusses the utilization of genetic mutation data in Sri Lankan patients with Duchenne muscular dystrophy (DMD), Spinal muscular atrophy (SMA), Spinocerebellar ataxia (SCA), and Huntington's disease (HD) to identify potential candidates for gene therapy. The authors compare the available literature from South Asian countries and emphasize the need for collaboration in gene therapy initiatives.

IBRO NEUROSCIENCE REPORTS (2023)

Article Multidisciplinary Sciences

Integrated genomic, proteomic and cognitive assessment in Duchenne Muscular Dystrophy suggest astrocyte centric pathology

Nalaka Wijekoon et al.

Summary: This study examines the correlation between serum protein signatures and cognitive performance in DMD patients of South Asian origin. The study identifies specific protein markers associated with better and worse cognitive performance in DMD. The findings suggest a common pathogenic mechanism between DMD and AD involving astrocytic dysfunction.

HELIYON (2023)

Article Clinical Neurology

Peak functional ability and age at loss of ambulation in Duchenne muscular dystrophy

Alberto A. Zambon et al.

Summary: This study aims to investigate the correlation between the North Star Ambulatory Assessment (NSAA) and timed rise from floor (TRF) with the age at loss of ambulation (LOA) in Duchenne muscular dystrophy (DMD). The findings show that higher functional abilities at peak are associated with older age at LOA in DMD. This information is important for counseling families and designing clinical trials.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2022)

Review Orthopedics

Global prevalence of Duchenne and Becker muscular dystrophy: a systematic review and meta-analysis

Nader Salari et al.

Summary: This study conducted a systematic review and meta-analysis to determine the global prevalence of DMD and BMD muscular dystrophies. The global prevalence was estimated to be 3.6 per 100,000 people, with the highest prevalence in the Americas. The study emphasizes the importance of prenatal screening and genetic counseling for families with a positive history to prevent the occurrence of genetic disorders.

JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2022)

Article Geriatrics & Gerontology

Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy

Mary Chesshyre et al.

Summary: This study highlights the importance of considering the expected effects of DMD mutations on dystrophin isoform production when evaluating motor impairments in DMD patients. Mutations that disrupt Dp140 and Dp71 are found to have a complex relationship with motor outcomes.

JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2022)

Article Clinical Neurology

Characteristics of disease progression and genetic correlation in ambulatory Iranian boys with Duchenne muscular dystrophy

Gholamreza Zamani et al.

Summary: This study investigated disease progression and genetic patterns in Iranian ambulant boys with DMD, finding a significant correlation between contracture and mutation type.

BMC NEUROLOGY (2022)

Article Cell Biology

Human Dystrophin Dp71ab Enhances the Proliferation of Myoblasts Across Species But Not Human Nonmyoblast Cells

Manal Farea et al.

Summary: Dystrophin Dp71ab, an isoform of Dystrophin Dp71, enhances the proliferation of myoblasts. It has a hydrophobic C-terminus and shows different cellular distributions compared to Dp71.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Multidisciplinary Sciences

Age, corticosteroid treatment and site of mutations affect motor functional changes in young boys with Duchenne Muscular Dystrophy

Giorgia Coratti et al.

Summary: The aim of this study was to investigate the possible effects of age, corticosteroid treatment, and brain dystrophin involvement on motor function in young boys with Duchenne Muscular Dystrophy. The study included 951 assessments from 226 patients and found that different brain dystrophin isoforms affected the maximum North Star score achieved. Linear regression analysis showed that age, site of mutation, and corticosteroid treatment influenced the NSAA values and their progression over time. The findings suggest that these variables should be considered in trial design for boys aged 4-7.

PLOS ONE (2022)

Article Biology

Loss of full-length dystrophin expression results in major cell-autonomous abnormalities in proliferating myoblasts

Maxime R. F. Gosselin et al.

Summary: In Duchenne muscular dystrophy (DMD), myoblasts are affected, leading to muscle degeneration and repair defects. These cells show abnormalities in gene expression and function, impacting muscle regeneration. Therefore, myoblasts can be a novel therapeutic target for the treatment of DMD.
Article Pediatrics

Patient demographics and characteristics from an ambispective, observational study of patients with duchenne muscular dystrophy in Saudi Arabia

Abdulaziz S. AlSaman et al.

Summary: This study conducted an observational research on DMD patients in Saudi Arabia and found that the diagnosis age of DMD is relatively late, indicating a need for improved adherence to international DMD standard of care guidelines. Therefore, there is an urgent requirement for improved DMD education and awareness among healthcare professionals and the public in Saudi Arabia.

FRONTIERS IN PEDIATRICS (2022)

Meeting Abstract Clinical Neurology

Expression and localization of dystrophin isoforms transcripts in human adult control brain areas

M. Falzarano et al.

NEUROMUSCULAR DISORDERS (2021)

Article Medicine, General & Internal

Duchenne muscular dystrophy

Dongsheng Duan et al.

Summary: Duchenne muscular dystrophy is a severe muscle-wasting disease caused by mutations in the DMD gene, leading to loss of muscle tissue and function as well as cardiomyopathy. Recent studies have deepened understanding of the disease and led to the development of multidisciplinary care guidelines and various therapeutic approaches.

NATURE REVIEWS DISEASE PRIMERS (2021)

Article Genetics & Heredity

Genotype characterization and delayed loss of ambulation by glucocorticoids in a large cohort of patients with Duchenne muscular dystrophy

Shu Zhang et al.

Summary: Genotype variations in DMD patients influence clinical progression, with all genotypes showing significant beneficial responses to GC treatment. Deletions amenable to skipping exon 44 had a lower hazard ratio compared to other genotypes, indicating a stronger protective effect of GC treatments on this subgroup. These findings are valuable for designing future clinical trials as clinical outcomes may be influenced by genotypes.

ORPHANET JOURNAL OF RARE DISEASES (2021)

Article Neurosciences

Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy

Michael Naidoo et al.

MOLECULAR NEUROBIOLOGY (2020)

Article Biochemistry & Molecular Biology

EMQN best practice guidelines for genetic testing in dystrophinopathies

Carl Fratter et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2020)

Article Clinical Neurology

Early developmental milestones in Duchenne muscular dystrophy

Paula van Dommelen et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2020)

Article Neurosciences

What We Fail to See in Neuro-Genetic Diseases: A Bird's Eye View from the Developing World

Navami Samaranayake et al.

ANNALS OF NEUROSCIENCES (2020)

Article Clinical Neurology

Longitudinal natural history in young boys with Duchenne muscular dystrophy

Giorgia Coratti et al.

NEUROMUSCULAR DISORDERS (2019)

Article Biochemistry & Molecular Biology

Repurposing Pathogenic Variants of DMD Gene and its Isoforms for DMD Exon Skipping Intervention

Rahul Tyagi et al.

CURRENT GENOMICS (2019)

Article Clinical Neurology

Current management of Duchenne muscular dystrophy in the Middle East: expert report

Mohammed Al Jumah et al.

NEURODEGENERATIVE DISEASE MANAGEMENT (2019)

Article Biochemistry & Molecular Biology

Detection of Dystrophin Dp71 in Human Skeletal Muscle Using an Automated Capillary Western Assay System

Tatsuya Kawaguchi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Behavioral Sciences

The Cerebellum: Adaptive Prediction for Movement and Cognition

Arseny A. Sokolov et al.

TRENDS IN COGNITIVE SCIENCES (2017)

Article Neurosciences

The Role of the Pediatric Cerebellum in Motor Functions, Cognition, and Behavior: A Clinical Perspective

Michael S. Salman et al.

NEUROIMAGING CLINICS OF NORTH AMERICA (2016)

Article Clinical Neurology

Duchenne/Becker muscular dystrophy: A report on clinical, biochemical, and genetic study in Gujarat population, India

Mandava V. Rao et al.

ANNALS OF INDIAN ACADEMY OF NEUROLOGY (2014)

Article Clinical Neurology

Early neurodevelopmental assessment in Duchenne muscular dystrophy

Marika Pane et al.

NEUROMUSCULAR DISORDERS (2013)

Article Clinical Neurology

Best Practice Guidelines on molecular diagnostics in Duchenne/Becker muscular dystrophies

Stephen Abbs et al.

NEUROMUSCULAR DISORDERS (2010)

Article Pediatrics

Delayed developmental language milestones in children with Duchenne's muscular dystrophy

Shana E. Cyrulnik et al.

JOURNAL OF PEDIATRICS (2007)

Article Clinical Neurology

Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols

WD Biggar et al.

NEUROMUSCULAR DISORDERS (2004)

Article Clinical Neurology

Developmental progress in Duchenne muscular dystrophy: lessons for earlier detection

EP Parsons et al.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2004)